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The present study investigated pharmacological characterizations of muscarinic acetylcholine receptor
(AChR) subtypes involving ACh-induced endothelium-independent vasodilatation in rat mesenteric ar-
teries. Changes in perfusion pressure to periarterial nerve stimulation and ACh were measured before
and after the perfusion of Krebs solution containing muscarinic receptor antagonists. Distributions of
muscarinic AChR subtypes in mesenteric arteries with an intact endotheliumwere studied using Western
blotting. The expression level of M1 and M3 was signiﬁcantly greater than that of M2. Endothelium
removal signiﬁcantly decreased expression levels of M2 and M3, but not M1. In perfused mesenteric
vascular beds with intact endothelium and active tone, exogenous ACh (1, 10, and 100 nmol) produced
concentration-dependent and long-lasting vasodilatations. In endothelium-denuded preparations,
relaxation to ACh (1 nmol) disappeared, but ACh at 10 and 100 nmol caused long-lasting vasodilatations,
which were markedly blocked by the treatment of pirenzepine (M1 antagonist) or 4-DAMP (M1 and M3
antagonist) plus hexamethonium (nicotinic AChR antagonist), but not methoctramine (M2 and M4
antagonist). These results suggest that muscarinic AChR subtypes, mainly M1, distribute throughout the
rat mesenteric arteries, and that activation of M1 and/or M3 which may be located on CGRPergic nerves
releases CGRP, causing an endothelium-independent vasodilatation.
© 2015 Japanese Pharmacological Society. Production and hosting by Elsevier B.V. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).tylcholine receptor; CGRP,
in gene-related peptide-con-
ridine; EDRF, endothelium-
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. Production and hosting by Else1. Introduction
Many studies have revealed ACh-induced vasorelaxation is
absolutely dependent on an intact endothelium and is mediated by
endothelium-derived relaxing factors (EDRF) including nitric oxide
(NO), prostanoids and endothelium-derived hyperpolarizing factor
(EDHF) (1e3). In vascular beds from various species, the activation
of muscarinic acetylcholine receptor (AChR) has been shown to
induce a potent vasodilatation via the release of EDRF from the
endothelium. Distribution of muscarinic AChR on vascular endo-
thelial cells has been reported to be associated with ACh-induced
vasodilatation (4).
Muscarinic AChR has been shown to be divided into 5 subtypes,
M1, M2, M3, M4, andM5 (5). M1, M2, andM3 have been reported tovier B.V. This is an open access article under the CC BY-NC-ND license (http://
P. Tangsucharit et al. / Journal of Pharmacological Sciences 130 (2016) 24e32 25be distributed in the vasculature including artery, vein, and endo-
thelium (6e8). It is well known the vascular endothelium has M1
and/or M3, and its activation induces a potent vasodilatation (9).
Remarkably, the expression pattern of muscarinic AChR subtypes
and their role in mediating vascular responses substantially differ
according to individual vascular beds (10e15). Many studies
conﬁrmed that ACh-induced vasodilatation is partially mediated by
M1, since selective M1 antagonist, pirenzepine, blunts the vasodi-
latation (10,16). However, Ren and coworkers reported, in isolated
simian coronary arteries, ACh induced both vasodilatation and
vasoconstriction via the activation of M3 on endothelium cells and
smooth muscle cells, respectively (16). Additionally, M3 in the
forearm vasculature has been shown to play a major role in ACh-
induced endothelium-dependent vasodilatation (17). Endothelial
M3 has been also reported to mediate ACh-induced vasodilatation
in murine retinal arterioles via the activation of NO synthase and in
cutaneous, skeletal muscle, and renal interlobar arteries (18).
Moreover, Chiba and Tsukada demonstrated there are abundant
functional M3 and a few M1 in the canine lingual artery in which
these receptors mediate an endothelium-dependent vasodilatation
(9). In contrast, neither M1 nor M5 subtypes appeared to be
involved in ACh-induced responses of cutaneous, skeletal muscle,
and renal interlobar arteries (19).
Takenaga et al. (20) reported interesting ﬁndings that ACh
induced an initial transient endothelium-dependent vasodilatation
followed by a secondary long-lasting endothelium-independent
vasodilatation in rat mesenteric vascular beds. This study demon-
strated the underlying mechanism of vasodilatation that ACh acti-
vated muscarinic receptors located on endothelium to cause an
initial rapid vasodilatation and presynaptic muscarinic receptors on
calcitonin gene-related peptide (CGRP)-containing neurons to
release CGRP, which then acted at postsynaptic CGRP receptors on
vascular smooth muscles to cause the endothelium-independent
vasodilatation. Furthermore, Shiraki et al. reported ACh-induced
endothelium-independent vasodilatation in rat mesenteric ar-
teries is inhibited by the muscarinic AChR antagonist, atropine, and
the part of atropine-resistant vasodilatation is abolished by hexa-
methonium (nicotinic AChR antagonist), guanethidine (adrenergic
neuron blocker) and capsaicin (CGRP depletor), suggesting that
adrenergic nerves via nicotinic AChR and CGRPergic nerves are
involved in ACh-induced endothelium-independent vasodilatation
(21). However, the detailed information on subtypes of muscarinic
AChR associated with ACh-induced endothelium-independent
vasodilatation remains unknown.
Therefore, the aim of this study was to investigate the distri-
bution and pharmacological characterization of muscarinic AChR
subtypes (M1, M2, andM3) involving in ACh-induced endothelium-
independent vasodilatation in rat mesenteric arteries.2. Materials and methods
2.1. Animals
A total of 60 male Wistar rats (Japan SLC Inc., Shizuoka, Japan)
weighing 250e350 g were used in this study. All animals were
given food and water ad libitum. They were housed in the Animal
Research Center of Okayama University at a controlled ambient
temperature of 22 ± 2 C with 50 ± 10% relative humidity and with
a 12-h light/12-h dark cycle (lights on at 8:00 a.m.). This study was
performed in accordance with the Guidelines for Animal Experi-
ments at Okayama University Advanced Science Research Center,
Japanese Government Animal Protection and Management Law
(No. 115), and Japanese Government Notiﬁcation on Feeding andSafekeeping of Animals (No. 6). Every effort was made to minimize
the number of animals used and their suffering. All experiments
conformed to international guidelines on the ethical use of animals.
2.2. Perfusion of mesenteric vascular beds
The animals were anesthetized with sodium pentobarbital
(50 mg/kg, i.p.) before the mesenteric vascular beds were isolated
and prepared for perfusion as described previously (22). The
mesenteric vascular bed was separated from the intestine by cut-
ting close to the intestinal wall, and four main arterial branches
from the superior mesenteric trunk running to the terminal ileum
were perfused with modiﬁed Krebs solution at a constant ﬂow rate
of 5 ml/min with a peristaltic pump (model AC-2120; ATTO Co.,
Tokyo, Japan). Changes in perfusion pressure weremeasured with a
pressure transducer (model TP-400T, Nihon Kohden, Tokyo, Japan)
and recorded using a pen recorder (model U-228, Nippon Denshi
Kagaku, Tokyo, Japan).
2.3. Chemical removal of the vascular endothelium
To remove the vascular endothelium, preparations were
perfused with sodium deoxycholate (1.80 mg/ml) for 30 s as
described previously (20,23). In preparations precontracted by
perfusion with Krebs solution containing 2 mM methoxamine,
successful removal of the endothelium was assessed by the lack of
vasodilatation to 1 nmol ACh, which was injected directly into the
perfusate proximal to the arterial cannula with an injection pump
(model 975, Harvard Apparatus, Holliston, MA, USA). The volume
injected was 100 mL over 12 s.
2.4. Cold-storage denervation
Isolated mesenteric vascular beds were stored in cold Krebs
solution at 4 C for 72 h to achieve cold-storage denervation (24). To
determine the intact responsiveness of smooth muscles, ACh or
CGRP was carried out to cause vasodilatation. Successful denerva-
tion of periarterial nerves was conﬁrmed by the lack of periarterial
nerve stimulation (PNS)-induced vasoconstrictions (8 and 12 Hz) at
resting tone and vasodilatation (2 Hz) at active tone.
2.5. Western blot analysis
The protein expression levels of M1, M2, andM3weremeasured
by western blot analysis. The mesenteric arteries were pulverized
and homogenized in Tis-buffered saline (25 mM TriseHCl (pH 7.4),
1 mM EDTA) containing 1% protease inhibitor cocktail. The tissue
extracts were centrifuged, and total protein content was quantiﬁed
using Lowry method. Proteins were diluted to 2.5 mg/ml, then
mixed 1:1 with sample buffer (62.5 mM TriseHCl, pH 6.8, con-
taining 25% glycerol, 2% sodium dodecyl sulfate, 5% 2-
mercaptoethanol, and 0.01% bromophenol blue) and denatured at
95 C for 5 min. Total proteins (12.5 mg/protein 10 mL) were sepa-
rated in a 12% polyacrylamide gel (Bio-Rad Laboratories Inc., Her-
cules, CA, USA), and then transferred onto polyvinylidene ﬂuoride
membrane using a protein blotting equipment consisting of a Mini-
PROTEAN Tetra Cell and a PowerPac HC (Bio-Rad Laboratories Inc.).
The membranes were blocked with 5% nonfat milk dissolved in
TBS-T buffer (25 mM TriseHCl buffer, pH 7.4, containing 0.15 M
sodium chloride (NaCl) and 0.1% Tween 20) for 1 h at room tem-
perature, and incubated with primary antibodies against rabbit
anti-M1, M2, or M3 (1: 200) (SigmaeAldrich, Tokyo, Japan) or anti-
b-actin (1: 2000) (Santa Cruz Biotechnology, Inc., TX, USA)
P. Tangsucharit et al. / Journal of Pharmacological Sciences 130 (2016) 24e3226overnight at 4 C, and then incubated with goat anti-mouse (1:
5000) (Santa Cruz Biotechnology) and goat anti-rabbit (1: 3000)
secondary antibodies (Santa Cruz Biotechnology) for 0.5 h at room
temperature. The membranes were washed and the blots were
visualized using Chemiluminescence Luminol Reagent (Santa Cruz
Biotechnology).
2.6. In vitro treatment with capsaicin
The depletion of CGRPergic nerves was performed according to
the method described by Kawasaki et al. (22,25). Successful
depletion of CGRPergic nerves was conﬁrmed by the lack of vaso-
dilatation in response to PNS (4 Hz).
2.7. Experimental protocols for PNS and pharmacological analysis
To prove ACh-induced endothelium-independent and
CGRPergic nerve-mediated vasodilatation, the mesenteric
vascular bed was perfused with Krebs solution containing
methoxamine (7 mM). After the elevated perfusion pressure had
stabilized, PNS (4 Hz) was applied for 30 s and then infusions
of ACh (1, 10, and 100 nmol) were performed (control). After
sodium deoxycholate or capsaicin was perfused in preparations
with resting tone followed by washing with normal KrebsFig. 1. Changes in muscarinic acetylcholine M1, M2, and M3 receptor (R) protein expression
(endothelium removal) and cold-storage denervation groups (n ¼ 6). In upper immunoreacti
about 55, 52, 67 kDa and 47 kDa, respectively. The quantitative value of M1, M2, and M3 ex
actin protein, by the densitometric analysis. Each column and bar indicates the mean ± S.Esolution, PNS and injections of ACh were carried out to
examine involvement of CGRPergic nerves and endothelium,
respectively.
In denuded preparations with active tone produced by perfu-
sion of Krebs solution containing methoxamine (2 mM), the
vascular response to the ﬁrst PNS (4 Hz; R1) and injections of ACh
(1, 10, and 100 nmol; I1) were obtained (control). The perfusion of
Krebs solution containing pirenzepine (1 mM), methoctramine
(100 nM) or 4-DAMP (10 nM) was begun 30 min before perfusion
of Krebs solution containing methoxamine (2 mM). After the
elevated perfusion pressure had stabilized, PNS (R2) and infusions
of ACh (I2) were carried out. In another series of vasodilator
response experiments, after the control responses to the ﬁrst PNS
(S1) and ACh injections (I1) were obtained in the presence of
pirenzepine or 4-DAMP, the second PNS (S2) and ACh injections
(I2) were carried out in the presence of hexamethonium and
pirenzepine or 4-DAMP. The effects of pirenzepine, methoctr-
amine, and 4-DAMP were expressed as the ratio between the
vascular responses (R2/R1 or I2/I1).
At the end of each experiment, the preparation was
perfused with 100 mM papaverine to cause a complete relaxa-
tion. Vasodilator activity was expressed as a percentage of the
perfusion pressure induced by maximum relaxation to
papaverine.in rat mesenteric arteries isolated from control, sodium deoxycholate (SD)-treatment
ve bands (A), molecular weights of M1, M2, and M3Rs and b-actin proteins indicated are
pression shown in (B) was normalized to the expression levels of the housekeeping b-
.M. **P < 0.01 vs. Control. ##P < 0.01 vs. M1 control.
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Experimental results are each expressed as the mean ± S.E.M.
Statistical analysis was performed by one-way analysis of variance
followed by Tukey's test. A value of P < 0.05 was considered sta-
tistically signiﬁcant.2.9. Drugs
The following reagents were used: acetylcholine chloride
(Daiichi Pharmaceutical, Tokyo, Japan), capsaicin (Sigma), hexa-
methonium bromide (Sigma), methoctramine (Sigma), methox-
amine hydrochloride (Nihon Shinyaku, Kyoto, Japan), papaverine
hydrochloride (Dainippon Pharmaceutical, Tokyo, Japan), pir-
enzepine hydrochloride (Sigma), sodium deoxycholate (IshizuFig. 2. A typical recording (A, B, and C) and bar graph (D) showing effects of sodium deoxyc
triangles) and injections of acetylcholine (ACh; 1, 10, and 100 nmol; solid circles) in mesente
and capsaicin treatments, respectively. SD, capsaicin and PPV indicate the perfusion of sodiu
D, ordinate indicates vasodilatation expressed as a percentage of the papaverine-induced m
**P < 0.01, compared with Control.Seiyaku), 4-diphenyl-acetoxy-N-methyl-piperidine methiodide (4-
DAMP) (Enzo Life Science). All drugs, except capsaicin and so-
dium deoxycholate, were dissolved in distilled water and diluted
with Krebs solution. Capsaicin was dissolved in 50% ethanol and
diluted with Krebs solution (ﬁnal alcohol concentration, 0.4 mg/
ml). Sodium deoxycholate was dissolved in 0.9% saline.3. Results
3.1. Western blot analysis of muscarinic AChR subtypes in rat
mesenteric arteries with intact endothelium
As shown in Fig. 1A, immunoreactive bands for M1, M2, and M3
subtypes were detected in rat mesenteric arteries with intact
endothelium. Major bands were present at 55, 52, and 67 kDa forholate and capsaicin treatment on vasodilatation induced by PNS (4 Hz; open inverted
ric vascular beds. A, B, and C show responses of control, after sodium deoxycholate (SD)
m deoxycholate for 30 s, capsaicin for 20 min and papaverine (100 mM), respectively. In
aximum relaxation. Values represent the mean ± S.E.M. of six experiments. *P < 0.05,
Fig. 3. Typical tracing showing vasodilator responses to PNS (4 Hz) and injections of acetylcholine (ACh; 1, 10, and 100 nmol) in mesenteric vascular beds with a denuded
endothelium without (A) or with (B) pirenzepine. R1, I1 and R2, I2 show the ﬁrst and second responses to PNS or injections of ACh, respectively. Solid circle, injection of ACh. Open
inverted triangles, PNS. SD and PPV indicate the perfusion of sodium deoxycholate and papaverine, respectively.
Fig. 4. Effects of pirenzepine (1 mM), methoctramine (100 nM) and 4-DAMP (10 nM) on vasodilator responses to periarterial nerve stimulation (PNS; 4 Hz) and acetylcholine (ACh;
10 and 100 nmol) injections. Ordinate shows the ratio of R1 and R2-and I1 and I2-induced vasodilatations. Each column and bar represents the mean ± S.E.M. of six experiments.
**P < 0.01, compared with Control.
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study (26). The expression level of M1 was 3.2 and 1.6 fold greater
than that of M2 and M3 subtypes, respectively (Fig. 1B). The level of
M3 expression was 2.0 fold greater than that of M2.
3.2. Changes in expression of muscarinic AChR subtypes after
endothelium removal or cold-storage denervation
The expressions of M1 were detected in rat mesenteric arteries
without endothelium and with cold-storage denervation, as
observed in control group (Fig. 1). However, expression levels of M2
and M3 subtypes were signiﬁcantly decreased in mesenteric ar-
teries without endothelium, but not with denervation, as compared
with control. The degrees of decrease were 55.3% and 15.8% for M2
and M3 subtype, respectively (Fig. 1B).
3.3. Effect of sodium deoxycholate and capsaicin treatment on ACh-
induced vasodilatation
PNS (4 Hz) induced an initial increase in perfusion pressure due
to vasoconstriction, which was followed by a long-lasting decrease
in perfusion pressure due to vasodilatation. The injection of ACh
(1 nmol) produced a rapid drop in perfusion pressure, which
occurred in 1e2 s after ACh injection. However, higher doses of ACh
(10 and 100 nmol) caused a rapid drop in perfusion pressure, fol-
lowed by long-lasing vasodilatation in which the second phase was
prolonged in a concentration-dependent manner, and the perfu-
sion pressure gradually returned to the pre-injection level within
10e20 min.Fig. 5. Typical recordings showing the effect of pirenzepine (1 mM) (A) or 4-DAMP (10 nM
iarterial nerve stimulation (PNS; 4 Hz) and injections of acetylcholine (ACh; 1, 10, and 100 nm
I2 show responses to the ﬁrst and second PNS or injections of ACh, respectively. Solid circle, i
perfusion of sodium deoxycholate.As shown in Fig. 2B, since chemical denudation of vascular
endothelium has been reported to augment the methoxamine-
induced increase in the perfusion pressure (23), the concentration
of methoxamine was decreased to 2 mM from 7 mM. The vasodilator
response to PNS 4 Hzwas not affected after removal of endothelium
(Fig. 2B). However, chemical denudation abolished the initial rapid
component of the vasodilatation in response to injections of ACh at
1, 10, and 100 nmol (Fig. 2B and D), and 10 and 100 nmol of ACh
produced long-lasting vasodilator responses in a concentration-
dependent manner.
As shown in Fig. 2C and D, after treatment with capsaicin at
5 mM for 20 min, vasodilator response to ACh at any doses and PNS
(4 Hz) was also not produced.
3.4. Effects of pirenzepine, methoctramine, and 4-DAMP on
endothelium-independent vasodilator responses to ACh
PNS (4 Hz; R1) induced an initial vasoconstriction followed by a
long-lasting vasodilatation in denuded preparations with active
tone (Fig. 3A and B). In this preparation, an injection of ACh
(1 nmol) did not caused vasodilatation, while injections of ACh (10
and 100 nmol) induced a concentration-dependent and long-
lasting vasodilatation (I1) (Fig. 3A). Repeated PNS (4 Hz; R2) and
injections of ACh (10 and 100 nmol) caused reproducible vasodi-
lator responses (I2). In the control response, ratios of R2/R1 were
0.92 ± 0.06 at 4 Hz and ratios of I2/I1 at 10 and 100 nmol were
0.99 ± 0.08 and 0.96 ± 0.13, respectively (Fig. 4).
There were no signiﬁcant differences in PNS-induced vasodila-
tation between the control and each antagonist-treated group. The) (B) and combination with hexamethonium (10 mM) on vasodilator responses to per-
ol) in perfused mesenteric vascular beds without an endothelium. R1 and R2 or I1 and
njections of ACh. Open inverted triangles, PNS. PPV, the perfusion of papaverine. SD, the
Fig. 6. Effects of pirenzepine (1 mM) (A) or 4-DAMP (10 nM) (B) and combination with
hexamethonium (10 mM) on vasodilator responses to periarterial nerve stimulation
(PNS; 4 Hz) and injections of acetylcholine (10 and 100 nmol) in perfused mesenteric
vascular beds without an endothelium. Bars represent vascular responses in the ratio
of R2/R1 and I2/I1. Each column and bar represents the mean ± S.E.M. of six experi-
ments. *P < 0.05, **P < 0.01, compared with Control.
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abolished by the treatment with pirenzepine and 4-DAMP, but not
methoctramine (Fig. 4).
3.5. Effect of hexamethonium on ACh-induced pirenzepine-resistant
vasodilatation
In the presence of pirenzepine (1 mM), the ﬁrst PNS (4 Hz; R1)
induced a long-lasting vasodilatation (62.03 ± 1.98%), and in-
jections of ACh (10 and 100 nmol; I1) caused a signiﬁcant dimin-
ished vasodilatation (2.70 ± 0.49% and 6.65± 1.04%) comparedwith
control. Furthermore, combined treatment with hexamethonium
(10 mM) and pirenzepine pronouncedly inhibited the vasodilatation
to an injection of ACh (100 nmol), but not to PNS (4 Hz), compared
with control and pirenzepine treatment (Figs. 5A and 6A).
3.6. Effect of hexamethonium on ACh-induced 4-DAMP-resistant
vasodilatation
In the presence of 4-DAMP (10 nM), PNS (4 Hz; R1) caused a
long-lasting vasodilator (81.33 ± 3.84%), but responses to ACh (10
and 100 nmol; I1) were markedly diminished (3.98 ± 0.87% and
6.04 ± 1.07%) compared with control (Fig. 6B). In the combined
presence of hexamethonium (10 mM) and 4-DAMP, the 2nd PNS
(R2) induced a similar vasodilator response (87.82 ± 6.73%) to the
control response (R1). However, responses to ACh (10 and
100 nmol; I2) were almost abolished (1.63 ± 0.18 and 2.45 ± 0.96%)
(Figs. 5B and 6B).
4. Discussions
There have been few studies on pharmacological characteriza-
tion, expression and distribution of the muscarinic receptor sub-
type mediating vascular responses in the rat mesenteric vascular
bed. Therefore, the present study using Western blot analysis is the
ﬁrst report to clearly demonstrate that M1, M2, and M3 were
detected in rat mesenteric arteries, and M1 and M3 expressions
were higher than that of M2, suggesting that both M1 and M3 have
a critical role in rat mesenteric arteries.
Stimulation of M1 and M3 has been reported to induce
endothelium-dependent vasodilatation in various blood vessels
from different species (9,19,27), implying that M1 and M3
distribute the endothelium. Hendriks et al. (28) demonstrated that
M3 was responsible for an endothelium-dependent vasodilatation
in response to methacholine in the perfused rat mesenteric
vascular bed. Therefore, to estimate possible distribution site of
these subtypes, endothelium removal with sodium deoxycholate
resulted in signiﬁcant decrease in the expression levels of M2 and
M3, whereas signiﬁcant reduction of M1 expression levels was not
observed, suggesting that M2 and M3 could partly distribute in the
endothelium. It is also suggested that muscarinic AChR might be
highly distributed in rat mesenteric smoothmuscle cells. Therefore,
high concentration of ACh (10 and 100 nmol)-induced vasodilata-
tions seems to be partially mediated by the stimulation of musca-
rinic AChR in vascular smooth muscles. However, our previous
study showed that exogenously applied ACh did not cause vascular
responses when functions of endothelium and CGRPegic nerves
were removed (29). It seems likely that muscarinic AChRs in the
vascular smooth muscle have no or less function.
Takenaga et al. (20) reported that the stimulation of muscarinic
AChR induced CGRPergic nerve-mediated vasodilatation, which
was abolished by cold-storage denervation, indicating that
muscarinic AChR was distributed in CGRPergic nerves. In the pre-
sent study, expression levels of M1 and M2, but not M3, were
slightly, but not signiﬁcantly, decreased by cold-storagedenervation, which induced mainly the functional loss of peri-
vascular nerves. It is also inferred that the cold-storage denervation
with short-time periods at 72 h could not destroy the structure of
nervous system including receptor proteins of M1 and M2. There-
fore, it seems likely that the perivascular denervation might cause a
slight decrease in M1 and M2 expression levels, since tissue vol-
umes of smooth muscle and endothelium in rat mesenteric arteries
were relatively greater than that of perivascular nerves. The present
results suggest that muscarinic M1, M2, and M3 are distributed in
rat mesenteric arteries, which include endothelium and peri-
vascular nerves, and contribute to induce endothelium- and peri-
vascular nerve-mediated vascular responses.
P. Tangsucharit et al. / Journal of Pharmacological Sciences 130 (2016) 24e32 31Interestingly, the present study showed that exogenous appli-
cation of ACh in the mesenteric artery without an endothelium
induced endothelium-independent vasodilatations, which was
signiﬁcantly abolished by elimination of CGRPergic nerve function
with the treatment of capsaicin. These ﬁndings are good accor-
dance with the previous report by Takenaga et al. (20) that exog-
enously applied ACh activates presynaptic muscarinic AChR located
on CGRP-containing neurons to release CGRP, which then acts at
postsynaptic CGRP receptors on vascular smooth muscles to cause
the endothelium-independent vasodilatation. However, it has not
been reported on the characterization of muscarinic AChR subtypes
involving ACh-induced endothelium-independent vasodilatation.
To clarify the uncertain facts, the present study demonstrated that
pirenzepine (M1 antagonist) and 4-DAMP (M1/M3 antagonist)
pronouncedly abolished the vasodilator response to ACh at 10 and
100 nmol in preparations without an intact endothelium and with
active tone. However, methoctramine (M2 antagonist) had no effect
on vasodilatation in response to ACh at any concentrations.
Therefore, it seems likely that M1 and M3 located on perivascular
nerves, but not vascular smooth muscle, are responsible for ACh-
induced endothelium-independent and CGRPergic nerve-
mediated vasodilatations.
In the present study, pirenzepine and 4-DAMP caused 68% and
53% inhibition of vasodilator response to 100 nmol ACh (Fig. 4). In
the presence of hexamethonium, pirenzepine or 4-DAMP strongly
abolished the vasodilator response to ACh at 100 nmol compared
with the administration of pirenzepine or 4-DAMP (Fig. 6A and B).
These ﬁndings are in line with the ﬁndings by Shiraki et al. (21),
who reported that high concentration of ACh produced atropine-
resistant endothelium-independent vasodilatation in rat mesen-
teric artery without an endothelium, which was abolished by
additional application of hexamethonium, implying that nicotinic
AChR is in part involved in the ACh-induced endothelium-inde-
pendent vasodilatation. Furthermore, additional studies revealed
evidence that nicotinic AChR agonist including nicotine and ACh
stimulates presynaptic nicotinic AChR on adrenergic nerves to
release protons, which then act on transient receptor potential
vanilloid 1 (TRPV1) located in CGRPergic nerves to release endog-
enous CGRP from the nerves (23,30,31). These studies and the
present results strongly suggest that a high concentration of ACh
induces adrenergic and CGRPergic nerve-mediated vasodilatation
via nicotinic and muscarinic M1 and M3, mainly M1.
In conclusion, the present study suggests that muscarinic AChRs,
mainly M1 subtypes, distribute rat mesenteric arteries, and that the
activation of M1 and M3, but not M2, which may be located on
CGRPergic nerves releases CGRP, thereby causing an endothelium-
independent vasodilatation.Conﬂicts of interest
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